Don’t forget there are two different types of GvHD and then that is separated into two further cohorts (adults and children). So yes, maybe you can produce enough cells for sr-aGvHD in children as the market is so minuscule.
Ann: Appendix 4D & Half-Year Financial Statements, page-85
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
-0.015(7.69%) |
Mkt cap ! $32.52M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 18.0¢ | $4.623K | 25.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15232 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 17000 | 1 |
View Market Depth
| Last trade - 12.01pm 11/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |